Royalty Report: Medical, Device, Surgical – Collection: 6158

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 10

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 10

Primary Industries

  • Medical
  • Device
  • Surgical
  • Catheter
  • Stent
  • Supply

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 6158

License Grant
The Licensee and the Licensors, two individuals, entered into a worldwide License agreement for  the Invention, including without limitation the entire right, title and interest to the Patent Rights to the  Atrial Septal Defect (ASD) and a Patent Ductus Arteriosus (PDA) Device Percutaneous Catheter Directed Intravascular Occlusion Devices – US Patent 5725552 .  The agreement shall continue in full force and effect for the commercial life of all products covered under this Agreement unless otherwise terminated. Inventors also grant the Licensee the exclusive right, but not the obligation, to use one or all of the inventors, names in its name or trademark for any Products and to use one or all of the inventors’ names in connection with the advertising and marketing of Products.  Intra-cardiac devices are used in various medical procedures
License Property
Atrial septal defect (ASD) is a form of congenital heart defect that enables blood flow between two compartments of the heart called the left and right atria.
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth.

IPSCIO Record ID: 6931

License Grant
During 2010 we had royalty agreements related to our AtriClip system, which is designed to safely and effectively exclude the left atrial appendage.
License Property
Our AtriClip system is designed to exclude the left atrial appendage by implanting the device during concomitant open surgical procedures from the outside of the heart, avoiding contact with the circulating blood pool while eliminating blood flow between the left atrial appendage and the atria. We believe that our AtriClip system is potentially safer, more effective and easier to use when permanently excluding the left atrial appendage than current products and techniques.
Field of Use
The rights granted apply to medical devices relating to the healthcare industry.

IPSCIO Record ID: 2663

License Grant
Seller, an individual, hereby sells, assigns, transfers and conveys to Purchaser all right, title and interest it has in and to the Patents and all inventions and discoveries described therein, including without limitation, all rights of Seller under the Assignment Agreement, and all rights of Seller to collect royalties under such Patents.
License Property
The Licensor (Seller) wishes to sell to the Licensee (Purchaser) all right, title and interest in the Patents 5,476,450. Apparatus and Method for Aspirating Intravascular, Pulmonary and Cardiac Obstructions.

IPSCIO Record ID: 195625

License Grant
Licensor, an individual, hereby agrees to assign to the Company all of his right, title and interest to the inventions (the 'Inventions') and related patent rights.
License Property
The Inventions shall consist of the inventions described in 'Daisy Occluder and Method for Septal Defect Repair' (U.S. Patent Application filed on August 28, 1996, App. No. 08/697,837).
Field of Use
08/697,837 (5,741,297) The present invention relates to an occluder structure and method for the repair of intracardiac and vascular septal defects, as well as other abnormal openings in tissue planes such as the abdominal wall.

A septum, which is a thin wall of muscle or tissue which divides two or more chambers of the heart or other anatomic spaces of the human body, sometimes is perforated by an abnormal aperture passing through the septum, described as a septal defect. When septal defects occur between adjacent chambers of the heart or its associated major blood vessels, blood can leak from one chamber or artery to another imposing added strain on the heart which may lead to heart failure. An opening in the abdominal wall may allow bowel to pass through it, causing a hernia.

The surgical repair of intracardiac defects has required the use of open chest surgical techniques wherein the defect is directly sutured shut.

IPSCIO Record ID: 6202

License Grant
The Licensor, an individual, assigned the patents for his inventions to certain pediatric cardiology medical devices and techniques and know-how to the Licensee.
License Property
Our Amplatzer occlusion devices offer minimally invasive, transcatheter treatments that have been clinically shown to be highly effective in defect closure.

Our AMPLATZER occlusion devices utilize our expertise in braiding nitinol, a metal alloy with superelastic and shape-memory characteristics, and designing transcatheter delivery systems.

IPSCIO Record ID: 5656

License Grant
Licensor grants to Licensee a worldwide non exclusive non transferable license under Licensed Technology to make, use, have made or sell Licensed Products.
License Property
Licensed Product(s) means external defibrillator(s) for defibrillating the atria of a heart with temporary catheters and/or heart wires for internal defibrillation which is covered in the country of manufacture and/or sale by one or more claims of a patent included in the Licensed Technology.  Licensor owns the exclusive rights to a U.S. Patent No. 5,207,219 and foreign counterparts thereof (hereinafter referred to as (Licensed Technology).
Field of Use
The rights granted apply to the heart.

IPSCIO Record ID: 5941

License Grant
Licensee acquired the exclusive rights to the CardioSEAL® cardiac septal repair implant from the Licensor, a non-profit health care organization.   In connection with this acquisition, the Licensee acquired all of the existing development, manufacturing, testing equipment, patent Licenses, know-how and documentation necessary to manufacture cardiac septal repair implant devices. Under the License Agreements, as amended, the Licensee pays royalties to the Licensor on all commercial sales of our cardiac septal repair products. The Territory for sales of CardioSEAL® is the United States, Canada and Europe. The Licensee sells STARFlex® in Europe.
License Property
CardioSEAL® and STARFlex® are revolutionary products designed to close different types of holes in the heart without open heart surgery.  CardioSEAL®, a third generation implant, is constructed from a low profile, metal framework shaped like an umbrella to which a knitted polyester fabric is securely attached. CardioSEAL is comprised of two of these umbrellas, one for each side of the septum. Both the metal and fabric are made from the most biocompatible materials known for this application. The framework in particular has been selected for its excellent biocompatibility profile. After all, this implant will be in place for the life of the patient.

The Licensee has an exclusive worldwide License from the Licensor under United States patents entitled Occluder and Method for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,425,744), Occluder for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,451,235) and Self-Centering Umbrella-Type Septal Closure Device (U.S. Patent No. 5,709,707) and the respective corresponding foreign patents, patent applications and associated know-how.

Field of Use
The rights granted apply to cardiac products.

IPSCIO Record ID: 4808

License Grant
In connection with its Septal repair device, the Company has obtained an exclusive worldwide license from the Licensor, a non-profit health care organization.
License Property
United States patents entitled Occluder and Method for Repair of Cardiac and Vascular Defects and Occluder for Repair of Cardiac and Vascular Defects and the respective corresponding foreign patents, patent applications and associated know-how.

IPSCIO Record ID: 257712

License Grant
The Licensee is obligated under the License Agreement to pay a royalty on the net sales of its  dual  use uterine monitoring catheter, AmCath,  to the Inventors, two individuals.
License Property
The dual use uterine monitoring catheter, AmCath, that allows simultaneous measurement of interuterine pressure during labor and a means for administering sterile isotonic solution.
Field of Use
The Licensee strives to develop new products in the areas of the medical device industry.

IPSCIO Record ID: 29104

License Grant
The Licensee has entered into an agreement with the Licensor, an individual, who shall provide technical assistance to the Licensee upon request,  to enable the Licensee to manufacture and market the Products or the Licensor's improvements thereto and to prosecute and enforce any Patent Rights.
License Property
The royalty obligations shall continue in full force for as long as the vascular graft, vascular plug, or vascular trap is covered by, or manufactured in accordance with the method recited in, one or more valid and enforceable claims of a patent issuing from or claiming priority to U.S. Patent No. 6,123,715.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.